Market Place
Sourcing Support
Carrick Doses First Patient In CT7439 Phase 1 Trial
23 Sep 2024 //
GLOBENEWSWIRE
Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts
05 Jun 2024 //
GLOBENEWSWIRE
Carrick Announces First Patient Dosed in Phase 1b/2 Trial of Samuraciclib
14 Feb 2024 //
GLOBENEWSWIRE
Carrick Announces First Patient Dosed in Phase 2b Clinical Trial of Samuraciclib
15 Dec 2023 //
GLOBENEWSWIRE
Carrick Announces First Patient Dosed in Phase 2 Trial of Samuraciclib
18 Oct 2023 //
GLOBENEWSWIRE
Carrick Therapeutics Announces U.S. FDA Clearance of IND for CT7439
07 Sep 2023 //
GLOBENEWSWIRE
Carrick Announces Trial Collab with Arvinas & Pfizer to Evaluate Samuraciclib
06 Jul 2023 //
GLOBENEWSWIRE
Carrick Therapeutics and Menarini to evaluate breast cancer combo therapy
20 Dec 2022 //
CLINICALTRIALSARENA
Carrick Therapeutics and Menarini to evaluate breast cancer combo therapy
20 Dec 2022 //
CLINICALTRIALSARENA
Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment
02 Dec 2022 //
ENDPTS
Carrick Therapeutics Announces $35 Million Investment from Pfizer
01 Dec 2022 //
GLOBENEWSWIRE
Carrick Therapeutics Closes Series C Financing
01 Dec 2022 //
GLOBENEWSWIRE
Carrick Presents Encouraging Clinical Data for Samuraciclib (CT7001)
09 Dec 2021 //
GLOBENEWSWIRE
Carrick Therapeutics to Present Clinical Data on Samuraciclib (CT7001)
22 Nov 2021 //
GLOBENEWSWIRE
Carrick Presents Encouraging data for Samuraciclib in Combo with Fulvestrant
16 Sep 2021 //
GLOBENEWSWIRE
FDA fast tracks breast cancer candidate samuraciclib
18 Aug 2021 //
PHARMA TIMES
Carrick Therapeutics to Present First Clinical Data on Samuraciclib
17 Aug 2021 //
GLOBENEWSWIRE
FDA fast tracks breast cancer candidate samuraciclib
16 Aug 2021 //
PHARMATIMES
Carrick Receives FDA Fast Track Designations for Two Samuraciclib Combinations
16 Aug 2021 //
GLOBENEWSWIRE
Carrick Announces Collaboration with Roche to Evaluate Samuraciclib Combination
02 Aug 2021 //
GLOBENEWSWIRE
Carrick Therapeutics Announces Collaboration with Roche
02 Aug 2021 //
GLOBENEWSWIRE
Carrick hires ex-Tesaro CFO, shifts focus toward U.S.
28 Jun 2019 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.